Home
Conditions
Nerve Sheath Neoplasms

Clinical trial condition

Nerve Sheath Neoplasms

Explore clinical trials studying Nerve Sheath Neoplasms. Study availability and eligibility vary by location and protocol.

344 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Nerve Sheath Neoplasms trial results

Recruiting

Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas

NCT04750928

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

NCT04222413

Conditions: Advanced Breast Cancer, Advanced Solid Tumors, Colonic Diseases, +32 more
Locations: University of Kansas Fairway, Kansas, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

NCT06880991

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

NCT05361811

Conditions: Abnormalities, Multiple, Cardiofaciocutaneous Syndrome, Cardiofaciocutaneous syndrome, +30 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Recruiting

SPEARHEAD-3 Pediatric Study

NCT05642455

Conditions: Fibrosarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neoplasms, +26 more
Locations: Stanford University Palo Alto, California, United States

National Institutes of Health Bethesda, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Washington University St Louis, Missouri, United States

View Trial Details

Recruiting

Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor

NCT07549022

Conditions: Fibrosarcoma, MPNST, Malignant Peripheral Nerve Sheath Tumors, +15 more
Locations: University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma

NCT04859335

Conditions: Cranial Nerve Diseases, Cranial Nerve Neoplasms, Dizziness, +24 more
Locations: CHU Toulouse Toulouse, France

View Trial Details

Recruiting

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

NCT02390752

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +22 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Natural History Study of Patients With Neurofibromatosis Type 2

NCT00598351

Conditions: Central Nervous System Diseases, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +38 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

NCT06735820

Conditions: Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, +24 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Nerve Sheath Neoplasms

Nerve Sheath Neoplasms trial results

Related conditions